DAIICHI SANKYO and Eli Lilly and Company
LONDON - Britons First to Benefit From Latest Heart Tablet Prasugrel (Efient(R) Black Triangle Drug)
UK patients are the first to benefit from the launch of a new heart drug prasugrel (Efient), following authorisation by the European Medicines Agency (EMEA).